Kelsey Jeffrey E
Georgia Institute of Mood and Anxiety Disorders, Atlanta, GA 30305-1537, USA.
J Am Osteopath Assoc. 2004 Mar;104(3 Suppl 1):S6-10.
Major Depressive Disorder (MDD) is a common clinical condition encountered in primary care practices. Left untreated or, more commonly, undertreated, MDD typically results in significant distress and dysfunction. Successful treatment of MDD, usually defined as achieving sustained remission, is an attainable goal. As such, sustained remission should be the goal sought by physicians and patients. A number of variables have an impact on the likelihood of achieving and sustaining remission including the length of the depressive episode, the completeness of the response to treatment, and whether remission is achieved relatively early in treatment. The selection of pharmacotherapeutic agents and the relative probability of achieving remission has only recently been investigated in outpatient populations, though this issue has been explored in inpatient studies for more than a decade. This article reviews these variables and presents strategies with the goal of achieving remission for patients with MDD. The importance of both pharmacotherapy, where indicated, as well as psychotherapy is discussed. Finally, remission is presented as a necessary first step to ensure an optimal long-term outcome, rather than as the final goal of treatment.
重度抑郁症(MDD)是基层医疗实践中常见的临床病症。若不治疗,或者更常见的是治疗不充分,MDD通常会导致严重的痛苦和功能障碍。成功治疗MDD,通常定义为实现持续缓解,是一个可以实现的目标。因此,持续缓解应是医生和患者所追求的目标。许多变量会影响实现和维持缓解的可能性,包括抑郁发作的时长、对治疗反应的完整性,以及缓解是否在治疗早期相对较早地实现。药物治疗药物的选择以及实现缓解的相对概率直到最近才在门诊患者中进行研究,尽管这个问题在住院患者研究中已经探讨了十多年。本文回顾了这些变量,并提出了旨在使MDD患者实现缓解的策略。文中讨论了在有指征时药物治疗以及心理治疗的重要性。最后,缓解被视为确保最佳长期预后的必要第一步,而不是治疗的最终目标。